Home › Funds › Redmile Group, LLC › IDYA

Redmile Group, LLC position in IDYA

IDEAYA BIOSCIENCES INC · Health Care

Redmile Group, LLC reported holding 640,202 shares of IDYA (IDEAYA BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$23.9M, representing 1.60% of its reported portfolio and ranking #14 among its reported holdings. Redmile Group, LLC has disclosed IDYA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)640.20K sh
Reported value held$23.86M
Portfolio Weight1.60%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's IDYA position evolved

Redmile Group, LLC first disclosed a stake in IDYA in Q4 2023 at 935,863 shares (US$33.3M). The position peaked in Q1 2024 at 922,678 shares, worth US$40.5M. Across 11 filings, Redmile Group, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 640,202 shares valued at US$23.9M — an increase of 119,085 shares quarter over quarter.. Notable position changes include a 72% increase in Q3 2025 (shares rose 27% over the following quarter), a 30% trim in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 935.86K $33.30M New
Q1 2024 922.68K $40.49M Reduce
Q2 2024 759.52K $26.67M Reduce
Q3 2024 681.15K $21.58M Reduce
Q4 2024 619.30K $15.92M Reduce
Q1 2025 534.60K $8.76M Reduce
Q2 2025 432.49K $9.09M Reduce
Q3 2025 742.02K $20.19M Add
Q4 2025 742.02K $25.65M Hold
Q1 2026 521.12K $17.36M Reduce
Q2 2026 640.20K $23.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IDYA and 13F data

IDYA (IDEAYA BIOSCIENCES INC) is a Health Care company. 38 other funds we track also report a position in IDYA — the largest reported positions include BAKER BROS. ADVISORS LP (US$186.7M), Logos Global Management LP (US$111.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$101.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IDYA

All IDYA fund holders →

FAQ

How long has Redmile Group, LLC held IDYA?

Redmile Group, LLC has disclosed IDYA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Redmile Group, LLC's current position in IDYA?

As of Q2 2026, Redmile Group, LLC holds 640.20K shares of IDYA (IDEAYA BIOSCIENCES INC), valued at $23.86M, representing 1.60% of its reported portfolio and ranking #14.

Has Redmile Group, LLC been buying or selling IDYA?

In the latest 13F filing (Q2 2026), Redmile Group, LLC increased its position in IDYA. The position peaked in Q1 2024 at 922.68K shares.

Which other funds hold IDYA?

Other major institutional holders of IDYA include BAKER BROS. ADVISORS LP, Logos Global Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.